Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000059478-19-000155)

Filing Details

Accession Number:: 0000059478-19-000155
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-04-16 14:36:52
Reporting Period:: 2019-04-12

Accepted Time:: 2019-04-16 14:36:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
59478	Lilly Eli & Co	LLY	Pharmaceutical Preparations (2834)	350470950

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1566364	S Melissa Barnes	Lilly Corporate Center Indianapolis IN 46285	Chief Eth/Cmpl Ofcr & Svp, Erm	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-04-12	4,735	$125.15	22,085	No	4	S	Direct
Common Stock	Disposition	2019-03-15	1,815	$0.00	20,270	No	4	G	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	G	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	897	Indirect	401(k)

Footnotes

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019.